Article
SHORT syndrome due to a novel de novo mutation in PRKCE (Protein Kinase Cɛ) impairing TORC2-dependent AKT activation.
Human molecular genetics - 1 Oct 2017
Alcantara Diana, Elmslie Frances, Tetreault Martine, Bareke Eric, Hartley Taila, Majewski Jacek, Boycott Kym, Innes A Micheil, Dyment David A, O'Driscoll Mark
Abstract excerpt
SHORT syndrome is a rare, recognizable syndrome resulting from heterozygous mutations in PIK3R1 encoding a regulatory subunit of phosphoinositide-3-kinase (PI3K). The condition is characterized by short stature, intrauterine growth restriction, lipoatrophy and a facial gestalt involving a triangular face, deep set eyes, low hanging columella and small chin. PIK3R1 mutations in SHORT syndrome result in reduced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
